Skip to main content
SpringerLink
Log in

Neurodegenerative Erkrankungen

Neue Kriterien für die Diagnose der Demenz mit Lewy-Körpern

  • zertifizierte fortbildung
  • Published:
InFo Neurologie & Psychiatrie Aims and scope

Zusammenfassung

Die hohe Zahl Erkrankter macht die Demenzen mit Lewy-Körpern zu einem Thema von Relevanz. Für die Diagnose bleibt die klinische Symptomatik wichtigster Anhaltspunkt und noch immer kann die Erkrankung nur symptomatisch behandelt werden. Neue Möglichkeiten der Bildgebung und ein Umdenken hinsichtlich der Pathophysiologie bilden die Basis für interessante Neuentwicklungen.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

1

Literatur

  1. McKeith, I.G., et al., Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology, 2017. 89(1): p. 88–100.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Aarsland, D., Cognitive impairment in Parkinson’s disease and dementia with Lewy bodies. Parkinsonism Relat Disord, 2016. 22 Suppl 1: p. S144–8.

    Article  PubMed  Google Scholar 

  3. Howlett, D.R., et al., Regional multiple pathology scores are associated with cognitive decline in Lewy Body Dementias. Brain Pathol, 2015. 25(4): p. 401–8.

    Article  CAS  PubMed  Google Scholar 

  4. Schulz-Schaeffer, W.J., Is cell death primary or secondary in the pathophysiology of idiopathic Parkinson’s Disease? Biomolecules, 2015. 5(3): p. 1467–79.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Uchihara, T. and B.I. Giasson, Propagation of alpha-synuclein pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies. Acta Neuropathol, 2016. 131(1): p. 49–73.

    Article  CAS  PubMed  Google Scholar 

  6. Dettmer, U., D. Selkoe, and T. Bartels, New insights into cellular alpha-synuclein homeostasis in health and disease. Curr Opin Neurobiol, 2016. 36: p. 15–22.

    Article  CAS  PubMed  Google Scholar 

  7. Sumi-Akamaru, H., et al., High expression of alpha-synuclein in damaged mitochondria with PLA2G6 dysfunction. Acta Neuropathol Commun, 2016. 4: p. 27.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Barthelemy, N.R., et al., differential mass spectrometry pofiles of Tau protein in the cerebrospinal fluid of Patients with Alzheimer’s Disease, Progressive Supranuclear Palsy, and Dementia with Lewy Bodies. J Alzheimers Dis. 2016;51(4):1033–43.

    Article  CAS  PubMed  Google Scholar 

  9. Lin, C.L., et al., Amyloid-beta suppresses AMP-activated protein kinase (AMPK) signaling and contributes to alpha-synuclein-induced cytotoxicity. Exp Neurol, 2016. 275 Pt 1: p. 84–98.

    Article  CAS  PubMed  Google Scholar 

  10. Pieri, L., et al., Cellular response of human neuroblastoma cells to alpha-synuclein fibrils, the main constituent of Lewy bodies. Biochim Biophys Acta, 2016. 1860(1 Pt A): p. 8–19.

    Article  CAS  PubMed  Google Scholar 

  11. Calo, L., et al., Synaptic failure and alpha-synuclein. Mov Disord, 2016. 31(2): p. 169–77.

    Article  CAS  PubMed  Google Scholar 

  12. Sampson, T.R., et al., Gut microbiota regulate motor deficits and neuroinflammation in a Model of Parkinson’s Disease. Cell, 2016. 167(6): p. 1469–1480 e12.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Aldecoa, I., et al., Alpha-synuclein immunoreactivity patterns in the enteric nervous system. Neurosci Lett, 2015. 602: p. 145–9.

    Article  CAS  PubMed  Google Scholar 

  14. Wahlund, L.O., et al., Imaging biomarkers of dementia: recommended visual rating scales with teaching cases. Insights Imaging, 2017. 8(1): p. 79–90.

    Article  PubMed  Google Scholar 

  15. Scheltens et al., Atrophy of medial temporal lobes on MRI in „probable“ Alzheimer’s disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry. 1992;55(10):967–72.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Pasquier et al., Inter- and intraobserver reproducibility of cerebral atrophy assessment on MRI scans with hemispheric infarcts. Eur Neurol. 1996;36(5):268–72.

    Article  CAS  PubMed  Google Scholar 

  17. Harper, L., et al., MRI visual rating scales in the diagnosis of dementia: evaluation in 184 post-mortem confirmed cases. Brain, 2016. 139(Pt 4): p. 1211–25.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Papathanasiou, N.D., et al., Diagnostic accuracy of 123I-FP-CIT (DaTSCAN) in dementia with Lewy bodies: a meta-analysis of published studies. Parkinsonism Relat Disord, 2012. 18(3): p. 225–9.

    Article  PubMed  Google Scholar 

  19. Shimizu, S., et al., Utility of the combination of DAT SPECT and MIBG myocardial scintigraphy in differentiating dementia with Lewy bodies from Alzheimer’s disease. Eur J Nucl Med Mol Imaging, 2016. 43(1): p. 184–92.

    Article  CAS  PubMed  Google Scholar 

  20. Brigo, F., G. Turri, and M. Tinazzi, 123I-FP-CIT SPECT in the differential diagnosis between dementia with Lewy bodies and other dementias. J Neurol Sci, 2015. 359(1-2): p. 161–71.

    Article  CAS  PubMed  Google Scholar 

  21. Treglia, G. and E. Cason, Diagnostic performance of myocardial innervation imaging using MIBG scintigraphy in differential diagnosis between dementia with lewy bodies and other dementias: a systematic review and a meta-analysis. J Neuroimaging, 2012. 22(2): p. 111–7.

    Article  PubMed  Google Scholar 

  22. Chiba, Y., et al., Early differential diagnosis between Alzheimer’s disease and dementia with Lewy bodies: Comparison between (18)F-FDG PET and (123)I-IMP SPECT. Psychiatry Res, 2016. 249: p. 105–12.

    Article  PubMed  Google Scholar 

  23. Walker, Z., et al., Lewy body dementias. Lancet, 2015. 386(10004): p. 1683–97.

    Article  PubMed  Google Scholar 

  24. Mishima, A., et al., Biomarkers Differentiating Dementia with Lewy Bodies from Other Dementias: A Meta-Analysis. J Alzheimers Dis, 2016. 50(1): p. 161–74.

    Article  CAS  PubMed  Google Scholar 

  25. Bousiges, O., et al., Diagnostic value of cerebrospinal fluid biomarkers (phospho-Tau181, total-Tau, Abeta42, and Abeta40) in prodromal stage of Alzheimer’s Disease and Dementia with Lewy Bodies. J Alzheimers Dis, 2016. 51(4): p. 1069–83.

    Article  CAS  PubMed  Google Scholar 

  26. Wang, Z.Y., et al., Use of CSF alpha-synuclein in the differential diagnosis between Alzheimer’s disease and other neurodegenerative disorders. Int Psychogeriatr, 2015. 27(9): p. 1429–38.

    Article  PubMed  Google Scholar 

  27. Petrova, M., et al., Investigation of neuropsychological characteristics of very mild and mild dementia with Lewy bodies. J Clin Exp Neuropsychol, 2016. 38(3): p. 354–60.

    Article  PubMed  Google Scholar 

  28. Heitz, C., et al., Cognitive and affective theory of mind in dementia with Lewy bodies and Alzheimer’s disease. Alzheimers Res Ther, 2016. 8(1): p. 10.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Chwiszczuk, L., et al., Higher frequency and complexity of sleep disturbances in Dementia with Lewy Bodies as compared to Alzheimer’s Disease. Neurodegener Dis, 2016. 16(3-4): p. 152–60.

    Article  CAS  PubMed  Google Scholar 

  30. Matsunaga, S., et al., Cholinesterase inhibitors for Lewy Body Disorders: A meta-analysis. Int J Neuropsychopharmacol, 2015. 19(2).

    Google Scholar 

  31. Matsunaga, S., T. Kishi, and N. Iwata, Memantine for Lewy body disorders: systematic review and meta-analysis. Am J Geriatr Psychiatry, 2015. 23(4): p. 373–83.

    Article  PubMed  Google Scholar 

  32. Wang, H.F., et al., Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson’s disease, Parkinson’s disease dementia, and dementia with Lewy bodies: systematic review with meta-analysis and trial sequential analysis. J Neurol Neurosurg Psychiatry, 2015. 86(2): p. 135–43.

    Article  PubMed  Google Scholar 

  33. Stinton, C., et al., Pharmacological Management of Lewy Body Dementia: A Systematic Review and Meta-Analysis. Am J Psychiatry, 2015. 172(8): p. 731–42.

    Article  PubMed  Google Scholar 

  34. Velayudhan L, Ffytche D, Ballard C, Aarsland D. New Therapeutic Strategies for Lewy Body Dementias. Curr Neurol Neurosci Rep. 2017;17(9):68

    Article  PubMed  Google Scholar 

  35. Brand, S., et al., [Depression in Parkinson’s disease. Assessment and treatment]. Nervenarzt, 2007. 78(6): p. 715–27.

    Article  CAS  PubMed  Google Scholar 

  36. Pagan, F., et al., Nilotinib Effects in Parkinson’s disease and Dementia with Lewy bodies. J Parkinsons Dis, 2016. 6(3): p. 503–17.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Elder, G.J., et al., Effects of transcranial direct current stimulation upon attention and visuoperceptual function in Lewy body dementia: a preliminary study. Int Psychogeriatr, 2016. 28(2): p. 341–7.

    Article  PubMed  Google Scholar 

  38. Groot, C., et al., The effect of physical activity on cognitive function in patients with dementia: A meta-analysis of randomized control trials. Ageing Res Rev, 2016. 25: p. 13–23.

    Article  CAS  PubMed  Google Scholar 

  39. Pena, J., et al., Improving functional disability and cognition in Parkinson disease: randomized controlled trial. Neurology, 2014. 83(23): p. 2167–74.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Zhang, Q., Y.C. Kim, and N.S. Narayanan, Disease-modifying therapeutic directions for Lewy-Body dementias. Front Neurosci, 2015. 9: p. 293.

    PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Essen, Deutschland

    Adina Wagner, Eric Tönnies, Sebastian Sennock, Lisa Leikeim, Anna Gronewold, Johanna Klag &  Richard Dodel

  2. Lehrstuhl für Geriatrie, Universitätsklinikum Essen, Geriatriezentrum Haus Berge, Contilia GmbH, Germaniastr. 1 – 3, 45356, Essen, Deutschland

    Richard Dodel

Authors
  1. Adina Wagner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eric Tönnies
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sebastian Sennock
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lisa Leikeim
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Anna Gronewold
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Johanna Klag
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Richard Dodel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Richard Dodel.

Additional information

Interessenkonflikt

Die Autoren erklären, dass sie sich bei der Erstellung des Beitrags von keinen wirtschaftlichen Interessen haben leiten lassen.

A. Wagner, A. Gronewold, J. Klag, L. Leikeim und S. Sennock werden von der Studienstiftung des deutschen Volkes gefördert. E. Tönnies wird von der Stiftung der Deutschen Wirtschaft gefördert. Für R. Dodel liegt dem Verlag ein COI entsprechend des International Committee of Medical Journal Editors (ICMJE) vor. Der Verlag erklärt, dass die inhaltliche Qualität des Beitrags von zwei unabhängigen Gutachtern geprüft wurde. Werbung in dieser Zeitschriftenausgabe hat keinen Bezug zur CME-Fortbildung.

Der Verlag garantiert, dass die CME-Fortbildung sowie die CMEFragen frei sind von werblichen Aussagen und keinerlei Produktempfehlungen enthalten. Dies gilt insbesondere für Präparate, die zur Therapie des dargestellten Krankheitsbildes geeignet sind.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wagner, A., Tönnies, E., Sennock, S. et al. Neue Kriterien für die Diagnose der Demenz mit Lewy-Körpern. InFo Neurologie 19, 36–46 (2017). https://doi.org/10.1007/s15005-017-2088-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15005-017-2088-2

Search

Navigation